🇨🇦 Canada Country × Condition
plaque psoriasis Clinical Trials in Canada
Active clinical trials for plaque psoriasis with research sites in Canada. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇨🇦 Canada
Active Trials in Canada (3)
NCT06382051
Recruiting
Modifying PEST for Psoriatic Arthritis Screening
Enrollment
502 pts
Country
🇨🇦 Canada
Novartis Pharmaceuticals
View Trial → NCT07039110
Recruiting
Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Enrollment
700 pts
Country
🇨🇦 Canada
AbbVie
View Trial → NCT07449702 Phase 2
Recruiting
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Enrollment
80 pts
Country
🇨🇦 Canada
Oruka Therapeutics, Inc.
View Trial → Frequently Asked Questions
How many plaque psoriasis clinical trials are active in Canada?
There are currently 3 active clinical trials for plaque psoriasis with sites in Canada, of which 3 are actively recruiting patients.
How can I join a plaque psoriasis clinical trial in Canada?
To join a plaque psoriasis clinical trial in Canada, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Canada directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are plaque psoriasis trials in Canada?
Active plaque psoriasis trials in Canada span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.